Medical Properties Trust, Inc. (MPW) Receives $14.19 Consensus PT from Analysts

Medical Properties Trust, Inc. (NYSE:MPW) has received an average rating of “Hold” from the ten ratings firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $14.19.

MPW has been the topic of a number of research analyst reports. JMP Securities set a $16.00 target price on Medical Properties Trust and gave the stock a “buy” rating in a research report on Monday, October 1st. Zacks Investment Research cut Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Thursday, October 25th. Stifel Nicolaus set a $14.00 target price on Medical Properties Trust and gave the stock a “hold” rating in a research report on Thursday, November 1st. Mitsubishi UFJ Financial Group lifted their target price on Medical Properties Trust to $15.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. Finally, ValuEngine upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Saturday, November 10th.

Medical Properties Trust stock traded down $0.52 during midday trading on Monday, reaching $16.97. The company’s stock had a trading volume of 12,131,385 shares, compared to its average volume of 2,788,679. Medical Properties Trust has a fifty-two week low of $11.82 and a fifty-two week high of $17.52. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.92 and a quick ratio of 4.92. The stock has a market cap of $6.38 billion, a PE ratio of 12.57, a P/E/G ratio of 3.25 and a beta of 0.50.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.01. Medical Properties Trust had a return on equity of 9.06% and a net margin of 124.88%. The company had revenue of $197.00 million for the quarter, compared to analysts’ expectations of $192.64 million. During the same period last year, the firm earned $0.33 earnings per share. Medical Properties Trust’s quarterly revenue was up 11.6% on a year-over-year basis. On average, research analysts expect that Medical Properties Trust will post 1.37 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 10th. Stockholders of record on Thursday, December 13th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.89%. The ex-dividend date is Wednesday, December 12th. Medical Properties Trust’s dividend payout ratio (DPR) is currently 74.07%.

In other news, Director Michael G. Stewart sold 5,800 shares of Medical Properties Trust stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $17.39, for a total transaction of $100,862.00. Following the sale, the director now owns 225,239 shares in the company, valued at $3,916,906.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Emmett E. Mclean sold 50,000 shares of the business’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $17.40, for a total value of $870,000.00. Following the completion of the transaction, the insider now owns 913,965 shares in the company, valued at approximately $15,902,991. The disclosure for this sale can be found here. Insiders have sold 111,265 shares of company stock worth $1,868,705 in the last quarter. Insiders own 0.83% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in Medical Properties Trust in the 2nd quarter valued at about $104,000. Cornerstone Wealth Management LLC acquired a new position in Medical Properties Trust in the 2nd quarter valued at about $583,000. Valeo Financial Advisors LLC acquired a new position in Medical Properties Trust in the 2nd quarter valued at about $128,000. Integrated Investment Consultants LLC acquired a new position in Medical Properties Trust in the 2nd quarter valued at about $136,000. Finally, Signaturefd LLC increased its position in Medical Properties Trust by 44.0% in the 2nd quarter. Signaturefd LLC now owns 11,349 shares of the real estate investment trust’s stock valued at $159,000 after acquiring an additional 3,468 shares during the period. Hedge funds and other institutional investors own 76.59% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: Catch-Up Contributions

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply